Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$107,369,251
+$13,504,700 QoQ
Shares Held
426,678
-1.1% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#243
of 4,153 holders
Holding Since
Sep 2020
24 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $567,998,433 across 14 Drug Manufacturers - General names. ABBV ranks #3 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
118,181 | $141,749,848 | |
| 2 | JNJ |
Johnson & Johnson
|
456,860 | $116,028,734 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
426,678 | $107,369,251 | |
| 4 | PFE |
Pfizer Inc
|
1,884,553 | $45,380,036 | |
| 5 | MRK |
Merck & Co., Inc.
|
323,733 | $41,599,690 | |
| 6 | NVS |
Novartis AG
|
185,906 | $29,135,188 | |
| 7 | AMGN |
Amgen Inc
|
79,199 | $28,679,541 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
229,499 | $13,223,732 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $107,369,251 | 426,678 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $93,864,551 | 431,581 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $93,879,000 | 410,867 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $90,674,305 | 391,614 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $65,213,132 | 351,326 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $70,954,995 | 338,655 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $61,690,687 | 347,162 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $70,059,782 | 354,769 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $63,882,624 | 372,450 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $55,741,720 | 306,105 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $44,803,531 | 289,111 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $42,206,189 | 283,149 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $45,407,512 | 337,026 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $47,098,137 | 295,527 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $57,598,127 | 356,402 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $48,042,482 | 357,965 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $44,152,658 | 288,278 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $44,162,978 | 272,426 | Shares | Sole | 2022-07-20 | |
| 2021-12-31 | $44,508,417 | 328,718 | Shares | Sole | 2022-07-25 | |
| 2021-09-30 | $36,195,347 | 335,546 | Shares | Sole | 2022-07-25 | |
| 2021-06-30 | $35,037,009 | 311,053 | Shares | Sole | 2022-07-26 | |
| 2021-03-31 | $33,076,577 | 305,642 | Shares | Sole | 2022-07-27 | |
| 2020-12-31 | $31,915,377 | 297,857 | Shares | Sole | 2022-07-28 | |
| 2020-09-30 | $20,348,120 | 232,311 | Shares | Sole | 2022-07-29 | |
| No filing history on record for this holder in this stock. | ||||||